Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Internal Medicine|March 19, 2023
Association of IgG4-related disease and systemic rheumatic disordersVeronica Batani, Marco Lanzillotta, Jasmin Mahajne, et al.
The Journal of Allergy and Clinical Immunology|May 13, 2014
De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related diseaseHamid Mattoo, Vinay S Mahajan, Emanuel Della-Torre, et al.
European Journal of Internal Medicine|January 6, 2020
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related diseaseCorrado Campochiaro, Emanuel Della-Torre, Marco Lanzillotta, et al.
United European Gastroenterology Journal|May 8, 2022
Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literatureSara Nikolic, Marco Lanzillotta, Nikola Panic, et al.
Journal of Neuroimmunology|December 3, 2013
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitisEmanuel Della-Torre, Laura Galli, Diego Franciotta, et al.
Nutrients|April 12, 2022
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort StudyValentina Cucca, Giuseppe A Ramirez, Patrizia Pignatti, et al.
Annals of the Rheumatic Diseases|May 13, 2014
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrationsZachary S Wallace, Hamid Mattoo, Mollie Carruthers, et al.
Hemasphere|May 26, 2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert PanelPier Luigi Zinzani, Marco Paulli, Luca Arcaini, et al.
Arthritis Research & Therapy|October 5, 2018
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapseMarco Lanzillotta, Emanuel Della-Torre, Raffaella Milani, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 10, 2021
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysisMarco Lanzillotta, Emanuel Della-Torre, Zachary S Wallace, et al.
Pageof 9